Affiliation:
1. Department of Rheumatology Université Paris‐Saclay, INSERM UMR1184, Assistance Publique–Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin Bicêtre Paris France
Abstract
The management of Sjögren's disease is challenging because of several factors. Indeed, the clinical presentations are heterogeneous, and one must be able to identify prognostic markers to adapt the follow‐up. In addition, there is no validated treatment. Nevertheless, international experts have been working for several years to establish recommendations to guide management. Since research in this field is extremely active, we anticipate the development of effective treatments for our patients in the near future.
Subject
Immunology,Rheumatology,Immunology and Allergy